Effect of tenecteplase versus alteplase on platelets during the first 3 hours of treatment for acute myocardial infarction: The Assessment of the Safety and Efficacy of a New Thrombolytic Agent (ASSENT-2) platelet substudy
- 30 April 2003
- journal article
- clinical trial
- Published by Elsevier in American Heart Journal
- Vol. 145 (4) , 636-642
- https://doi.org/10.1067/mhj.2003.210
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: